A detailed history of Vident Advisory, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Vident Advisory, LLC holds 46,557 shares of TEVA stock, worth $855,717. This represents 0.02% of its overall portfolio holdings.

Number of Shares
46,557
Holding current value
$855,717
% of portfolio
0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $594,998 - $810,091
46,557 New
46,557 $757 Million
Q4 2023

Feb 14, 2024

BUY
$8.12 - $10.63 $94,029 - $123,095
11,580 Added 39.72%
40,732 $425 Million
Q3 2023

Feb 21, 2024

SELL
$7.48 - $10.7 $86,618 - $123,905
-11,580 Reduced 28.43%
29,152 $297 Million
Q3 2023

Nov 14, 2023

BUY
$7.48 - $10.7 $218,056 - $311,926
29,152 New
29,152 $297 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $20.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Vident Advisory, LLC Portfolio

Follow Vident Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Advisory, LLC with notifications on news.